218 related articles for article (PubMed ID: 22741940)
1. Oral zinc therapy for zinc deficiency-related telogen effluvium.
Karashima T; Tsuruta D; Hamada T; Ono F; Ishii N; Abe T; Ohyama B; Nakama T; Dainichi T; Hashimoto T
Dermatol Ther; 2012; 25(2):210-3. PubMed ID: 22741940
[TBL] [Abstract][Full Text] [Related]
2. Oral treatment of pressure ulcers with polaprezinc (zinc L-carnosine complex): 8-week open-label trial.
Sakae K; Yanagisawa H
Biol Trace Elem Res; 2014 Jun; 158(3):280-8. PubMed ID: 24691900
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Polaprezinc (Zinc Compound) on Zinc Deficiency: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials Using Individual Patient Data.
Furihata K; Tsuchikawa M; Miwa T; Naito Y; Oba K; Sakagami M
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316581
[TBL] [Abstract][Full Text] [Related]
4. Effects of polaprezinc on morphological change of the tongue in zinc-deficient rats.
Kinomoto T; Sawada M; Ohnishi Y; Yamaguchi T; Tsuge S; Ogawa S; Washizuka M; Minaguchi J; Mera Y; Takehana K
J Oral Pathol Med; 2010 Sep; 39(8):617-23. PubMed ID: 21054547
[TBL] [Abstract][Full Text] [Related]
5. Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in rats.
Kono T; Asama T; Chisato N; Ebisawa Y; Okayama T; Imai K; Karasaki H; Furukawa H; Yoneda M
Life Sci; 2012 Jan; 90(3-4):122-30. PubMed ID: 22100444
[TBL] [Abstract][Full Text] [Related]
6. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
Murakami-Nakayama M; Tsubota M; Hiruma S; Sekiguchi F; Matsuyama K; Kimura T; Moriyama M; Kawabata A
J Pharmacol Sci; 2015 Feb; 127(2):223-8. PubMed ID: 25727961
[TBL] [Abstract][Full Text] [Related]
7. Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer Chemotherapy.
Fujii H; Hirose C; Ishihara M; Iihara H; Imai H; Tanaka Y; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K; Suzuki A
Anticancer Res; 2018 Nov; 38(11):6367-6373. PubMed ID: 30396959
[TBL] [Abstract][Full Text] [Related]
8. Polaprezinc (Zinc-L-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions: A Pilot Study.
Sakae K; Suka M; Yanagisawa H
J Clin Psychopharmacol; 2020; 40(6):599-606. PubMed ID: 33044355
[TBL] [Abstract][Full Text] [Related]
9. Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients.
Fukushima T; Horike H; Fujiki S; Kitada S; Sasaki T; Kashihara N
Ther Apher Dial; 2009 Jun; 13(3):213-9. PubMed ID: 19527468
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of zinc-carnosine chelate compound, Polaprezinc, enemas in patients with ulcerative colitis.
Itagaki M; Saruta M; Saijo H; Mitobe J; Arihiro S; Matsuoka M; Kato T; Ikegami M; Tajiri H
Scand J Gastroenterol; 2014 Feb; 49(2):164-72. PubMed ID: 24286534
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.
Himoto T; Hosomi N; Nakai S; Deguchi A; Kinekawa F; Matsuki M; Yachida M; Masaki T; Kurokochi K; Watanabe S; Senda S; Kuriyama S
Scand J Gastroenterol; 2007 Sep; 42(9):1078-87. PubMed ID: 17710674
[TBL] [Abstract][Full Text] [Related]
12. [Development of polaprezinc research].
Takei M
Yakugaku Zasshi; 2012; 132(3):271-7. PubMed ID: 22382829
[TBL] [Abstract][Full Text] [Related]
13. Zinc-L-Carnosine Complex (Polaprezinc) for the Treatment of Binge Eating: Three Case Reports.
Sakae K; Yanagisawa H
J Clin Psychopharmacol; 2017 Dec; 37(6):734-736. PubMed ID: 28926352
[No Abstract] [Full Text] [Related]
14. Residence time of polaprezinc (zinc L-carnosine complex) in the rat stomach and adhesiveness to ulcerous sites.
Furuta S; Toyama S; Miwa M; Itabashi T; Sano H; Yoneta T
Jpn J Pharmacol; 1995 Apr; 67(4):271-8. PubMed ID: 7650862
[TBL] [Abstract][Full Text] [Related]
15. [Involvement of zinc in taste disturbance occurring during treatment for malignant tumor in the chest and the effects of polaprezinc oral disintegrating tablets (a retrospective study)].
Nakata Y; Hirashima T; Kondou Y; Tokuoka Y; Imazato H; Iwata K; Oomori Y; Yamato A; Shimizu S; Nagao S; Matsui K; Abe N
Gan To Kagaku Ryoho; 2008 Jun; 35(6):955-9. PubMed ID: 18633224
[TBL] [Abstract][Full Text] [Related]
16. Polaprezinc, a zinc compound, is distributed to the lingual epithelium and increases its zinc concentration in zinc-deficient rats.
Hamano H; Yoshinaga K; Tanaka T; Eta R; Horii T; Kawabata Y; Furuta S; Takei M
Life Sci; 2009 Nov; 85(21-22):759-64. PubMed ID: 19846043
[TBL] [Abstract][Full Text] [Related]
17. Effect of polaprezinc on taste disorders in zinc-deficient rats.
Hamano H; Yoshinaga K; Eta R; Emori Y; Kawasaki D; Iino Y; Sawada M; Kuroda H; Takei M
Biofactors; 2006; 28(3-4):185-93. PubMed ID: 17473379
[TBL] [Abstract][Full Text] [Related]
18. Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer.
Watanabe T; Ishihara M; Matsuura K; Mizuta K; Itoh Y
Int J Cancer; 2010 Oct; 127(8):1984-90. PubMed ID: 20104529
[TBL] [Abstract][Full Text] [Related]
19. Basal protrusion of ulcers induced by endoscopic submucosal dissection (ESD) during treatment with proton pump inhibitors, and the suppressive effects of polaprezinc.
Inaba T; Ishikawa S; Toyokawa T; Ishikawa H; Miyahara K; Wato M; Kawai K; Okada H; Yamamoto K
Hepatogastroenterology; 2010; 57(99-100):678-84. PubMed ID: 20698249
[TBL] [Abstract][Full Text] [Related]
20. Effects of zinc supplementation on serum zinc concentration and ratio of apo/holo-activities of angiotensin converting enzyme in patients with taste impairment.
Takaoka T; Sarukura N; Ueda C; Kitamura Y; Kalubi B; Toda N; Abe K; Yamamoto S; Takeda N
Auris Nasus Larynx; 2010 Apr; 37(2):190-4. PubMed ID: 19716667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
